Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Feb 2025.
- Notable investors include City Light Capital, Run Ventures, Benhamou Global Ventures, Deepwater Asset Management, AI Fund — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Affineon
- ·The full record, as it builds
Funding rounds
No funding rounds for Affineon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Affineon
Developer of a workflow automation platform intended to enhance communication efficiency within healthcare settings. The company's system streamlines inbox workflows and reduces cognitive load by performing functions such as analyzing lab results, renewing prescriptions, and responding to patient messages, among others, enabling the healthcare industry to speed-read patients' charts, contextualize and correlate lab results into pre-processed summaries for providers to review, along with pre-processing patient messages.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2023
- Employees
- 20
- Website
- affineon.com/
- Ownership
- Privately Held (backing)
Affineon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Affineon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Affineon in its N-PORT filings yet. We sweep new filings monthly.